Cleared Traditional

K112770 - NVISION VLE IMAGING SYSTEM, NVISION VLE CATHETER (FDA 510(k) Clearance)

Dec 2011
Decision
84d
Days
Class 2
Risk

K112770 is an FDA 510(k) clearance for the NVISION VLE IMAGING SYSTEM, NVISION VLE CATHETER. This device is classified as a System, Imaging, Optical Coherence Tomography (oct) (Class II - Special Controls, product code NQQ).

Submitted by Ninepoint Medical, Inc. (Hillsborough, US). The FDA issued a Cleared decision on December 16, 2011, 84 days after receiving the submission on September 23, 2011.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 892.1560. This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging..

Submission Details

510(k) Number K112770 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2011
Decision Date December 16, 2011
Days to Decision 84 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NQQ - System, Imaging, Optical Coherence Tomography (oct)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1560
Definition This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging.

Similar Devices - NQQ System, Imaging, Optical Coherence Tomography (oct)

All 9
LIA Console (542-7)
K251730 · Leadoptik, Inc. · Dec 2025
HyperVue™ Imaging System - Integrated
K253101 · Spectrawave, Inc. · Dec 2025
deepLive (OSP12 + DMS)
K252851 · Damae Medical · Oct 2025
HyperVue™ Software
K251198 · Spectrawave, Inc. · Jul 2025
OPUSWAVE Dual Sensor Imaging System
K250684 · Terumo Cardiovascular Systems Thi Plant · Jul 2025
OPXION Optical Skin Viewer (OPXSV1-01F)
K242924 · Opxion Technology, Inc. · Jun 2025